Companies must find a way to make the most of the new technology
Votes boost libertarian president but lawmakers strike down plan to restore income tax for high earners
The legislation taking effect next month comes as the state becomes a top solar power
Towns weigh up their future after climate-fuelled disaster strikes agricultural powerhouse of Rio Grande do Sul
Global demand for the US currency remains extremely robust while appetite for the renminbi has soured
European specialist is planning seven 2x funds and six inverse funds focused on companies such as Apple and Meta
Oxford professor first to estimate magnitude of buyout managers’ incentive fees taxed at lower capital gains rate
Moscow and Havana strengthen ties on back of Ukraine war and Caribbean island’s dire economic situation
Ruling is setback for Javier Milei’s cash-strapped government as it faces cases brought by former foreign investors
Corporate needs you to find the differences . . .
Verdict makes defendant first child of a president to be found guilty of a crime
Adviser to libertarian leader says South American country can provide hedge against restrictions in the US and Europe
Republican efforts to pin the son’s sins on the president have intensified with Trump’s legal woes
Plus, the UK taxman comes for private equity and a Trump donor gatecrashes a charged deal
The risks of holding Treasuries are rising with increasing deficits
Direct lenders are coming under increased competitive pressure
The US stock market accounted for $56bn of the $116bn pumped into exchange traded funds
Peso slides after Claudia Sheinbaum backs proposed reforms that could lead to direct election of top justices
Wall Street group begins probe after online video shows man punching person at Brooklyn Pride event
Don’t greenback in anger
The former presidential candidate says she will vote for Trump — but her supporters aren’t so sure
Rampant inflation could push Nevadans to vote for Republican president for first time in 20 years
Until now its brand of multiculturalism has set an example to the rest of the developed world
Several months of fund outflows mark the decline of ESG as a marketing tool
Two developers of drugs for inflammatory diseases are latest to disregard poor performance of newly listed companies
UK Edition
